Advanced Search
LIU Juan, YAO Shu-kun, YIN Fei. Expression and Significance of RBL2/P130 in Hepatocellular Carcinoma[J]. Cancer Research on Prevention and Treatment, 2011, 38(06): 675-678. DOI: 10.3971/j.issn.1000-8578.2011.06.017
Citation: LIU Juan, YAO Shu-kun, YIN Fei. Expression and Significance of RBL2/P130 in Hepatocellular Carcinoma[J]. Cancer Research on Prevention and Treatment, 2011, 38(06): 675-678. DOI: 10.3971/j.issn.1000-8578.2011.06.017

Expression and Significance of RBL2/P130 in Hepatocellular Carcinoma

More Information
  • Received Date: May 09, 2010
  • Revised Date: July 22, 2010
  • ObjectiveTo investigate the expression and clinical significance of RBL2/P130 in primary human hepatocellular carcinoma(HCC). MethodsThe expression of RBL2/P130 in HCC, adjacent noncancerous cirrhotic liver and normal liver was detected by immunohistochemical technique. The relationship between RBL2/P130 and clinical parameters of HCC was analyzed. ResultsThe positive expression rate of RBL2/P130 was 34.1% in HCC, significantly lower than that of adjacent noncancerous cirrhotic liver and normal liver(χ2=11.7,P<0.01). The expression of RBL2/P130 was related to portal vein cancer embolus, tumor differentiation degree and tumor stage, but not to age, gender, tumor foci number, tumor size, tumor envelope integrity, AFP and HbsAg. Moreover, accumulative survival rate was significantly higher in positive expressed group than that in negative expressed group (P=0.014). ConclusionThe expression of RBL2/P130 was significantly lower in HCC and was closely related to tumor differentiation degree, development, invasion and metastasis.
  • Related Articles

    [1]YANG Qian, YE Dongxue, MA Yanran, HU Xiaoyuan, LI Hong, ZHOU Xuan, XIANG Fenggang. EIF5A2 Expression in Hepatocellular Carcinoma and Its Relation with Postoperative Survival[J]. Cancer Research on Prevention and Treatment, 2021, 48(6): 617-624. DOI: 10.3971/j.issn.1000-8578.2021.20.1437
    [2]YANG Zhenhua, YE Liang, FANG Surong, GU Wei. Clinical Significance of Immunohistochemistry in Detecting Epidermal Growth Factor Receptor Mutation in Lung Cancer[J]. Cancer Research on Prevention and Treatment, 2016, 43(4): 272-276. DOI: 10.3971/j.issn.1000-8578.2016.04.007
    [3]ZHOU Linyan, WAN Meizhen, LIU Yongping, CHEN Yufang. Assessment of Microsatallite Instability in Colorectal Carcinoma: A Comparison Between Immunohistochemistry and PCR Method[J]. Cancer Research on Prevention and Treatment, 2015, 42(12): 1231-1234. DOI: 10.3971/j.issn.1000-8578.2015.12.013
    [4]ZHANG Meng, PENG Li, QIAO Zhi-bin, HE Hong-tao, ZHOU Ye, XU Zhuo, YANG Tao, LIANG Zhan-qiang. Expression and Clinical Significance of pAkt, Skp2 and P27kip1 Protein in Hepatocellular Carcinoma[J]. Cancer Research on Prevention and Treatment, 2011, 38(11): 1283-1287. DOI: 10.3971/j.issn.1000-8578.2011.11.017
    [5]LIU Hua-qing, HU-Li. Application of Combination of Double-labelling with Immunohistochemistry and Laser Capture Microdissection in Hodgkin's Lymphoma[J]. Cancer Research on Prevention and Treatment, 2010, 37(04): 438-440. DOI: 10.3971/j.issn.1000-8578.2010.04.019
    [6]LI Shi-de, ZHANG Xiang-min, ZHUO Xiang-long. Expression and Relativity of Rb,Rb2/p130 Gene in Osteosarcoma[J]. Cancer Research on Prevention and Treatment, 2008, 35(09): 643-646. DOI: 10.3971/j.issn.1000-8578.2546
    [7]HAN Biao, ZHANG Xian-wei, LIU Jian, JIANG Peng. Expression of pRb2/p130, cyclinD1 and MUC1 in Esophageal Squamous Cell Carcinoma[J]. Cancer Research on Prevention and Treatment, 2006, 33(09): 649-652. DOI: 10.3971/j.issn.1000-8578.1323
    [8]PENG Li, ZUO Lian-fu, WANG Xiao-ling, ZHANG Meng, WANG Shun-xiang, ZHANG Feng-rui, TANG Rui-feng. Cyclooxygenase-2 Expression in Human Hepatocellular Carcinoma and Its Relationship with Angiogenesis[J]. Cancer Research on Prevention and Treatment, 2005, 32(04): 199-201. DOI: 10.3971/j.issn.1000-8578.696
    [9]CHEN Chun-mei, XIA He-shun, WU Jian-Ping, . A Study on Fiberbronchoscope,Clinicopathology and Immunohistochemistry of Lung Small Cell Carcinoma[J]. Cancer Research on Prevention and Treatment, 1999, 26(5): 344-346.
    [10]Xiong Yongyan, . Observations on Histology and Immunohistochemistry in NasopharyngealVesicular Nucleus Cell Carcinoma and Undifferentiated Carcinoma[J]. Cancer Research on Prevention and Treatment, 1996, 23(2): 81-82.

Catalog

    Article views (2163) PDF downloads (535) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return